Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs Vanguard Tax Managed Fund FTSE Developed Markets ETF (VEA) Price & Performance

Dr. Reddy's Laboratories Ltd Common StockTrade
Vanguard Tax Managed Fund FTSE Developed Markets ETFTrade

Price performance (Past 24H)

Key statistics

Dr. Reddy's Laboratories Ltd Common Stock vs Vanguard Tax Managed Fund FTSE Developed Markets ETF — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B), while Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $69.04 (market cap $323.80B). The key difference: Vanguard Tax Managed Fund FTSE Developed Markets ETF is far larger — about 30.5× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Vanguard Tax Managed Fund FTSE Developed Markets ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Vanguard Tax Managed Fund FTSE Developed Markets ETF for 132 Days on average.

RDYVEA
Market Cap
$10.61B$323.80B
Volume
3,738,8697,840,398
Sector
Health—
52-Week High
$15.38$73.79
52-Week Low
$11.38$58.90
Typical Hold Time
0 Days132 Days
Enterprise Value
$10.51B—
Dividend Yield
0.65%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Vanguard Tax Managed Fund FTSE Developed Markets ETF

VEA trades at $70.06 with minimal daily movement (+0.16%). The technical outlook is bearish with moving averages signaling weakness, though oscillators remain neutral. Recent news highlights VEA's competitive advantages including a low 0.03% expense ratio and higher dividend yield compared to peers. Institutional activity shows mixed signals with some firms increasing positions while others reduced exposure.

The ETF's focus on developed international markets provides stability but faces currency and geopolitical risks. Current bearish technical signals suggest near-term caution, though the fund's cost efficiency and diversification benefits support long-term international exposure. Key risks include global economic slowdowns and currency fluctuations affecting returns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RDY
100% Buy0% Sell
Avg holding period · 0 Days
VEA
92% Buy8% Sell
Avg holding period · 132 Days

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →

About Vanguard Tax Managed Fund FTSE Developed Markets ETF

The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Read more on VEA →